Keyword: Eli Lilly


Lilly Invests $2.1 Billion in New Indiana Facilities

08.06.2022 -

US drugmaker Eli Lilly has announced plans to invest $2.1 billion to expand its manufacturing footprint by setting up two new sites in Boone County, Indiana. The...


Bachem and Lilly Partner on Oligonucleotide APIs

27.04.2022 -

Bachem, a Swiss specialist in the development manufacture and manufacture of peptides and oligonucleotides, has entered into a strategic collaboration with major...

Markets & Companies

After the Big Covid-19 Storm

19.04.2022 -

What does 2022 hold for the biopharma industry? Which companies can play at the forefront in terms of products as well as business? Covid-19 will continue to be a...


Lilly Launches Institute for Genetic Medicine

25.02.2022 -

US drugmaker Eli Lilly is investing about $700 million to establish an institute for researching and developing genetic medicines at a new site in the Seaport area of...


Lilly Spends $1.5 Billion on US, Ireland Expansions

10.02.2022 -

Lilly has announced plans to spend more than $1.5 billion on new manufacturing facilities in the US and Ireland, as it beefs up its global network to meet rising demand...


Lilly and Foghorn in Oncology Collaboration

20.12.2021 -

Loxo Oncology at Lilly and Foghorn Therapeutics are collaborating to create novel oncology medicines based on the latter’s Gene Traffic Control platform. Under the terms...


Lilly Creates Neuroscience and Immunology Business Units

20.08.2021 -

US drugmaker Eli Lilly has announced changes to its executive leadership team as it creates two new business units in order to strengthen its focus on introducing...


Lilly Takes Full Control of Protomer Technologies

23.07.2021 -

US drugmaker Eli Lilly has acquired Protomer Technologies, strengthening its diabetes portfolio. The deal gives Lilly full control over the privately held US biotech...